Document is current
Any future updates will be listed below
-
Authors
Li, Tingting
Dai, Yaqing
Fu, Xiaobin
Cai, Qunrong
Ke, Dongmei
Yao, Qiwei
Li, Jiancheng
-
Funding
Funding for this research was provided by:
The National Clinical Key Specialty Construction Program, 2021; Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy (2020Y2012)
- License Information
-
More Information
Article History
Received: 19 February 2024
Accepted: 13 November 2024
First Online: 18 November 2024
Change Date: 13 November 2025
Change Type: Update
Change Details: The original article has been updated: Affiliation 1 has been updated.
Declarations
:
: This clinical study (CHICTR2000039499) was approved by the China Ethics Committee of Registering Clinical Tri. All patients provided written informed consent prior to treatment, and all information was anonymized prior to analysis. The study was performed in accordance with Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
